GLP Analogs
GLP-2 (TZ) Research Peptide
A synthetic dual GIP/GLP-1 receptor agonist peptide referenced in in-vitro receptor pharmacology literature. Laboratory reference compound. For research use only.
$49.99 — 5mg vial
| Purity | ≥99% |
| Quantity | 5mg |
| Molecular Weight | 4813.45 g/mol |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Leu-Asp-Lys(γGlu-C20 diacid)-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ |
| Category | GLP Analogs |
| Latest batch tested | 07/24/26 |
GLP-2 (TZ) in Research
GLP-2 (TZ) is a synthetic 39-amino-acid dual-incretin research peptide engineered to activate both the GIP receptor and the GLP-1 receptor. The dual-agonist design is the defining feature of its in-vitro pharmacology literature, which examines how simultaneous incretin-receptor engagement alters downstream cAMP signaling compared with single-receptor agonists.
Supplied lyophilized at 5mg and ≥99% HPLC purity with independent batch verification. For receptor-count comparisons, the catalog also carries the single-receptor GLP-1 (SM) analog and the tri-receptor GLP-3 (RT).
Research Overview
- Investigated for superior HbA1c reduction through dual incretin receptor activation
- Studied for significant body weight reduction via complementary appetite pathways
- Research into triglyceride reduction and improved lipoprotein profiles
- Explored for hepatic steatosis reduction and liver fat clearance
- Preclinical studies on synergistic GIP/GLP-1 receptor pharmacology
Quality & Testing
Every GLP-2 (TZ) batch is verified by independent third-party HPLC and mass-spectrometry testing, with a batch-specific certificate of analysis available on the COA page.
Laboratory Handling & Storage
Lyophilized peptides are supplied as a freeze-dried powder and are most stable stored cold (2–8°C), protected from light and moisture, in the original sealed vial. Under these conditions the research literature generally reports multi-year integrity for dry peptide material.
Once reconstituted in a laboratory setting, solutions are typically stored refrigerated and used within the window appropriate to the diluent and compound; repeated freeze–thaw cycles are avoided because they can promote aggregation. See our research overview on reconstitution and lyophilization for the underlying formulation science.
GLP-class analogs carry fatty-acid side chains; laboratory protocols typically allow reconstituted solutions to dissolve undisturbed rather than shaking.
Frequently Asked Questions
What is GLP-2 (TZ)?
GLP-2 (TZ) is Aurum's catalog designation for a synthetic dual GIP/GLP-1 receptor agonist peptide used in in-vitro incretin-receptor pharmacology research.
How does it differ from GLP-1 (SM) and GLP-3 (RT)?
The three compounds span one, two, and three receptor targets: GLP-1 (SM) engages the GLP-1 receptor alone, GLP-2 (TZ) adds GIP-receptor agonism, and GLP-3 (RT) adds glucagon-receptor activity. Together they form a receptor-count comparison series for research.
Is a COA available for this compound?
Yes — every lot ships with independent HPLC purity (≥99%) and MS identity documentation, published on the COA page with the batch number printed on the vial.
Is GLP-2 (TZ) for human use?
No. This is a laboratory reference compound for in-vitro and preclinical research only. It is not a pharmaceutical product and not for human consumption.